← Dashboard
Aug 12, 2026 11:50 AM ET
Catalyst
FDA/Bio
PROTAGONIST THERAPEUTICS: "STRONG BUY" ICOTYDE FDA APPROVAL AND PN-881 ADVANCEMENT - SEEKINGALPHA
FDA approval of Icotype and PN-881 advancement
What changed
Why it matters
FDA approval of Icotype and PN-881 advancement
Sources
seekingalpha
Related signals
PHASE 1 OF INDIA - US TRADE PACT HINGES ON SECTION 301 PROBE , OFFICIAL SAYS →
PITNEY BOWES OUTLINES PHASE 2 STRATEGIC REVIEW WHILE PUSHING NEAREST DEBT MATURITY TO MARCH 2029 - SEEKINGALPHA →
UNICYCIVE PLUMMETS FOLLOWING SECOND CRL FOR OLC FOR HYPERPHOSPHATEMIA - SEEKINGALPHA →
← Dashboard
Aug 12, 2026 11:50 AM ET